Results
114
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
114 companies
CSPC Pharmaceutical Group
Market Cap: HK$120.2b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$10.51
7D
-4.1%
1Y
122.7%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$13.1b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.44
7D
0.7%
1Y
171.7%
China Shineway Pharmaceutical Group
Market Cap: HK$6.3b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.32
7D
0.6%
1Y
3.1%
Jacobson Pharma
Market Cap: HK$3.0b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.49
7D
2.8%
1Y
156.9%
Ab&B Bio-Tech JS
Market Cap: HK$20.3b
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.
2627
HK$51.50
7D
9.2%
1Y
n/a
3SBio
Market Cap: HK$74.3b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$31.08
7D
-7.3%
1Y
442.4%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.04
7D
4.8%
1Y
226.9%
Innovent Biologics
Market Cap: HK$170.3b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$99.45
7D
2.0%
1Y
128.9%
Sino Biopharmaceutical
Market Cap: HK$146.1b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$8.17
7D
4.5%
1Y
160.2%
Brii Biosciences
Market Cap: HK$1.4b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$2.00
7D
-6.1%
1Y
108.3%
Guangzhou Innogen Pharmaceutical Group
Market Cap: HK$24.2b
Engages in development of drugs.
2591
HK$53.00
7D
-7.4%
1Y
n/a
WuXi Biologics (Cayman)
Market Cap: HK$134.0b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$32.92
7D
6.4%
1Y
220.9%
Akeso
Market Cap: HK$158.8b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$176.90
7D
6.9%
1Y
285.4%
Uni-Bio Science Group
Market Cap: HK$955.4m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.16
7D
10.3%
1Y
201.9%
Grand Pharmaceutical Group
Market Cap: HK$34.0b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$9.70
7D
15.6%
1Y
131.0%
WuXi XDC Cayman
Market Cap: HK$69.5b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.70
7D
-7.3%
1Y
204.0%
TYK Medicines
Market Cap: HK$6.0b
A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.
2410
HK$15.73
7D
-23.0%
1Y
-27.2%
Qyuns Therapeutics
Market Cap: HK$6.0b
A clinical-stage biotech company, focuses on the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.
2509
HK$27.18
7D
21.0%
1Y
14.4%
Extrawell Pharmaceutical Holdings
Market Cap: HK$301.1m
An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.
858
HK$0.13
7D
-2.3%
1Y
231.6%
Mabpharm
Market Cap: HK$3.3b
A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.
2181
HK$0.81
7D
9.5%
1Y
121.9%
Beijing Luzhu Biotechnology
Market Cap: HK$5.0b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$24.98
7D
6.3%
1Y
9.3%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.1b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$1.85
7D
-14.0%
1Y
50.4%
BioDlink International
Market Cap: HK$1.8b
An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
1875
HK$2.30
7D
-2.5%
1Y
24.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$10.0b
A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.
2315
HK$25.00
7D
1.5%
1Y
284.6%
Fusen Pharmaceutical
Market Cap: HK$255.1m
An investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.
1652
HK$0.34
7D
-2.8%
1Y
-64.1%
HBM Holdings
Market Cap: HK$9.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.44
7D
2.1%
1Y
1,020.7%
Ocumension Therapeutics
Market Cap: HK$9.2b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$11.32
7D
3.7%
1Y
111.6%
Genor Biopharma Holdings
Market Cap: HK$2.4b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$4.65
7D
24.7%
1Y
244.4%
Ascentage Pharma Group International
Market Cap: HK$33.7b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$90.65
7D
5.3%
1Y
215.9%
CARsgen Therapeutics Holdings
Market Cap: HK$11.7b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.
2171
HK$21.06
7D
-7.2%
1Y
469.2%
Hua Medicine (Shanghai)
Market Cap: HK$3.4b
Engages in the development and commercialization of drugs for the treatment of diabetes in China.
2552
HK$3.47
7D
-0.6%
1Y
201.7%
XtalPi Holdings
Market Cap: HK$40.9b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$10.17
7D
9.9%
1Y
57.7%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$106.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$466.60
7D
7.5%
1Y
184.3%
Transcenta Holding
Market Cap: HK$1.6b
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$3.94
7D
15.9%
1Y
185.5%
Shanghai Junshi Biosciences
Market Cap: HK$47.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$34.22
7D
6.9%
1Y
190.0%
Medtide
Market Cap: HK$5.8b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$40.64
7D
13.0%
1Y
n/a